José Valentín
García Gutiérrez

Profesor/a Asociado/a en CC. de la Salud

Foto de José Valentín

Foto de Hospital Universitario de Valladolid

Hospital Universitario de Valladolid

Valladolid, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (5)

2024

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
Leukemia
Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis
HemaSphere
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology

2015

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
Cancer Medicine, Vol. 4, Núm. 7, pp. 995-1002

2014

Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?
American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211